Next Article in Journal
Plant Spices as a Source of Antimicrobial Synergic Molecules to Treat Bacterial and Viral Co-Infections
Next Article in Special Issue
Chemical Composition, Antioxidant, Anti-Bacterial, and Anti-Cancer Activities of Essential Oils Extracted from Citrus limetta Risso Peel Waste Remains after Commercial Use
Previous Article in Journal
Toward High-Energy-Density Aqueous Lithium-Ion Batteries Using Silver Nanowires as Current Collectors
Previous Article in Special Issue
Collection of Hairy Roots as a Basis for Fundamental and Applied Research
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 27
Issue 23
10.3390/molecules27238209
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antioxidant, Antimicrobial, Cytotoxicity, and Larvicidal Activities of Selected Synthetic Bis-Chalcones

by
Aswathi Moothakoottil Kuttithodi
1,
Divakaran Nikhitha
1,
Jisha Jacob
1,
Arunaksharan Narayanankutty
2,*,
Manoj Mathews
3,
Opeyemi Joshua Olatunji
4,*,
Rajakrishnan Rajagopal
5,
Ahmed Alfarhan
5 and
Damia Barcelo
6
1
Molecular Microbial Ecology Lab, PG and Research Department of Zoology, St. Joseph’s College (Autonomous), Devagiri, Calicut 680 555, Kerala, India
2
Division of Cell and Molecular Biology, PG and Research Department of Zoology, St. Joseph’s College (Autonomous), Devagiri, Calicut 673 008, Kerala, India
3
PG and Research Department of Chemistry, St. Joseph’s College (Autonomous), Devagiri, Calicut 673 008, Kerala, India
4
African Genome Center, Mohammed VI Polytechnic University, Ben Guerir 43150, Morocco
5
Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
6
Water and Soil Research Group, Department of Environmental Chemistry, IDAEA-CSIC, Jordi Girona 18–26, 08034 Barcelona, Spain
*
Authors to whom correspondence should be addressed.
Molecules 2022, 27(23), 8209; https://0-doi-org.brum.beds.ac.uk/10.3390/molecules27238209
Submission received: 15 October 2022 / Revised: 16 November 2022 / Accepted: 18 November 2022 / Published: 25 November 2022
(This article belongs to the Special Issue Natural Bioactive Compounds and Human Health)
Browse Figures
Versions Notes

Abstract

:
Plants are known to have numerous phytochemicals and other secondary metabolites with numerous pharmacological and biological properties. Among the various compounds, polyphenols, flavonoids, anthocyanins, alkaloids, and terpenoids are the predominant ones that have been explored for their biological potential. Among these, chalcones and bis-chalcones are less explored for their biological potential under in vitro experiments, cell culture models, and animal studies. In the present study, we evaluated six synthetic bis-chalcones that were different in terms of their aromatic cores, functional group substitution, and position of substitutions. The results indicated a strong antioxidant property in terms of DPPH and ABTS radical-scavenging potentials and ferric-reducing properties. In addition, compounds 1, 2, and 4 exhibited strong antibacterial activities against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Salmonella enteritidis. The disc diffusion assay values were indicative of the antibacterial properties of these compounds. Overall, the study indicated the antioxidant and antimicrobial properties of the compounds. Our preliminary studies point to the potential of this class of compounds for further in vivo investigation.

1. Introduction

Plants are an important component of the biosphere that is essential for the sustainability of entire ecosystems [1]. They act as the primary source of food for other organisms, which are primarily composed of carbohydrates [2]. Apart from that, these plants are also home to a wide variety of compounds. Phytochemicals are important components obtained from plants by various methods and they are used as food and medicinal compounds by various populations in India and around the world [3]. Most compounds of plant origin are useful for their biological and pharmacological properties. [4]. A majority of these are allelochemicals that are known to repel various pests that attach to these plants [5,6]. Various biochemicals such as flavonoids, alkaloids, saponins and phenolic compounds are a useful part of medicine [7]. Compounds are extracted from almost all parts of a plant including the root, bark, flower, leaf, etc. Fatty oils, both essential and non-essential, and many active compounds can be seen in different parts of a single plant. Some produce medicinal effects whereas some produce toxic effects.
Plant products including primary and secondary metabolites are widely applied in the pharmacological field and nutritional aspects. These biochemical products are “side-tracks” or secondary metabolites that are essential in plant growth and development, protection, attraction or signaling. The main chemical groups of bioactive compounds in plants include polyphenols, flavonoids, anthocyanins, tannins, and chalcones. Flavonoids are an important class of bioactive compounds of plant origin. Flavonoid compounds possess antioxidant, antimicrobial, antiviral, and antitumor activities. The intake of large amounts of flavonoids can help prevent cancer and heart disease. Structurally, they are further classified into chalcones, flavones, isoflavones, flavanols, and anthocyanins. A chalcone is a compound that consists of two aromatic rings linked by an unsaturated 𝛼, 𝛽-ketone. Chalcones are a class of bioactive plant metabolites that are equipped with numerous biological and pharmaceutical benefits to humans. Plants belonging to the Leguminosae, Asteraceae and Moraceae families are rich in natural chalcones [8,9]. The radical-quenching abilities of the chalcones isolated from different plants have been widely reported [10,11]. The Angelica keiskei-derived chalcones have been shown to block the activities of cysteine proteases of the COVID virus [12]. A pharmacological analysis has indicated the antiradical and anti-edematous properties of these A. keiskei chalones [13]. Later, studies by Shin et al. [14] found that A. keiskei chalcones inhibit cytokine production in macrophages. Further, Enoki et al. [15] indicated that 4-hydroxyderricin (4-HD) and xanthoangelol, the two major chalcones in the plant, inhibit the development of diabetes via peroxisome-proliferator-activated receptor-gamma activation in mice. Likewise, the extracted chalcones from different species of Artocarpus inhibited platelet aggregation in vitro [16]. Ngameni et al. [17] indicated the potential of Dorstenia turbinata chalcones to inhibit brain tumor cell proliferation and invasion by blocking MMP2. The bioavailability of chalcones, i.e., the proportion of chalcone that enters the circulation when introduced into the body and its ability to have an effect, is low. The issue itself has important implications for the pharmaceutical applications of chalcones or their derivative molecules. [18]. Structurally, dibenzylidines or bis-chalcones also belong to the chalcone family [19]. Synthetic chalcones and bis-chalcones have therefore become more important than the naturally present chalcones. However, the medical properties of bis-chalcones are less known. The chalcones are also known for the inhibition of microbial populations, especially bacteria and fungi [20,21]. Further, these compounds are known to inhibit diseases associated with oxidative damage and inflammation [22].
Plant chalcones are flavonoid derivatives formed in the biosynthetic pathway of flavonols. They do not accumulate in plants in larger quantities; hence, the availability of these compounds is too limited from plant sources. Another challenge that limits the potential of chalcones is their low half-life. In this work, we synthesized six bis-chalcone compounds whose structures are shown in Figure 1. Compounds 1 to 3 are cyclohexanone derivatives while compounds 4 to 6 are cyclopentanone derivatives. We report the properties of these synthetic bis-chalcones as antioxidant molecules and antibacterial and larvicidal agents.

2. Results and Discussion

2.1. Characterization of Compounds

Phytochemicals are important compounds that are present in different plant parts at different concentrations [23]. These compounds are produced as part of the metabolic pathway or as secondary metabolites. Chalcones are one of the few bioactive compounds in plants [18]; they are known to have strong pharmacological activities against infectious and chronic diseases [24]. However, these molecules have a lower biological availability in humans. To overcome this issue, various synthetic chalcones/bis-chalcones have been chemically synthesized and studied [25,26]. In the present study, we evaluated six synthetic bis-chalcones for their biological efficacies. The synthetic chalcones were characterized by FT-IR and NMR spectroscopy techniques and high-quality figures are included in Supplementary Figures S1–S13.

2.2. Antiradical Potentials of Various Synthetic Bis-Chalcones

The synthetic bis-chalcones exhibited strong antioxidant activity; the scavenging of DPPH, nitric oxide, and ABTS radicals was high in compound 1 and compound 2, whereas compounds 5 and 6 were the least active (Table 1). The FRAP assay identified the EC50 values of compounds A, B, and C; the highest activity was shown by compound A (EC50 of 1.35 ± 0.10 µg/mL). This was followed by compound B (5.24 ± 0.21 µg/mL) and compound C (12.4 ± 0.20 µg/mL). The results indicated the antioxidant properties of the selected bis-chalcones, especially for compounds 1, 2, and compound 4. As can be seen from the structure, all of these molecules have the –Cl group as a substitution in their aromatic core unit. Strong radical-scavenging, reducing and enzyme inhibitory properties of these molecules can be attributed to the presence of the chlorine substitution in these bis-chalcones. Our results showed the ability of bis-chalcones to strongly inhibit the DPPH radical and reduce ferric ions. Antioxidant abilities eventually help to reduce oxidative radicals from various biological systems and thereby prevent the development of oxidative stress [27,28]. Oxidative damage induced by free radicals results in the progression of degenerative disorders including diabetes, obesity, cardiovascular problems, and neoplasia [29,30]. Hence, synthetic bis-chalcones may be helpful to prevent the development and progression of various oxidative-stress-associated diseases.

2.3. Synthetic Bis-Chalcones as Antimicrobial Agents

The selected synthetic bis-chalcones exhibited varying toxicity against the bacterial strains (Table 2); compound 2 was the most active against Escherichia coli (22.5 ± 0.2 mm). Similarly, compound 2 and compound 4 had LC50 values of 57.6 ± 3.2 and 69.7 ± 2.4 µg/mL. Previous studies have also indicated their bactericidal properties against various pathogenic microbial organisms [31,32,33]. Emerging studies have also indicated that chalcones and their derivatives prevent biofilm formation in bacterial colonies [34,35,36] and enhance antibiotic sensitivity [37,38]. The bacterial strains used are pathogenic to humans and animals as well as known to be lethal in many conditions [39,40]. The infection of P. aeruginosa has been widely associated with patients of cancers, organ transplantation and HIV [41]. Additionally, there have also been raising concerns about antibiotic resistance over the years. Likewise, S. aureus and S. enteritidis are also associated with infections of the digestive tract in foodborne diseases [42,43]. Hence, the inhibitory potential of bis-chalcones on various microbes may indicate their potential as antibiotic agents for future use.

2.4. Larvicidal Activity of Synthetic Bis-Chalcones

Apart from their antioxidant properties, it was also noted that the bis-chalcones exhibited larvicidal properties. The larvicidal property of the synthetic bis-chalcones revealed stronger activity in compound 1 (45.27 ± 2.34 µg/mL), compound 2 (59.81 ± 2.09 µg/mL), and compound 4 (56.46 ± 3.07 µg/mL) (Table 3). Limited studies are available on the potential of synthetic chalcones or their derivatives against mosquito larvae. Previous studies by Targanski et al. [44], Begum et al. [45] and Pasquale et al. [46] are among the few that indicated the potential of chalcones against Aedes aegypti. Mosquitoes are important vectors of various diseases including arboviral diseases [47], Chikungunya [48], and dengue [49]. Further, the recent literature has indicated that mosquitoes are also involved in the spreading of Zika viral infections [50]. Therefore, the beneficial larvicidal potential of synthetic bis-chalcones may be helpful in the management of infectious diseases.
The cytotoxicity evaluation was performed against two human breast cancer cells, MCF-7 and MDA-MB-231 (Table 4). The MCF-7 cell expresses receptors for estrogen, epidermal growth factor, and progesterone [51,52,53]. On the contrary, MDA-MB-231 is a cell with basal expression for these three receptors and is often considered to be “triple negative” [54,55,56]. The chalcones were more toxic towards the MCF-7 cells compared to MDA-MB-231 in terms of the IC50 values. Previous studies have also reported the anticancer potentials of chalcones and their derivatives in various cell and animal models [57,58]. In addition, the fact that the synthetic chalcones are in a purified form means their applicability in medicine is higher than that of crude extracts or isolated plant products.
Further studies are also necessary to ascertain the safety aspects of these synthetic bis-chalcones against various non-target organisms, freshwater fishes and germinating seeds. This will ensure a bis-chalcone-based synthetic pesticide, which is an efficient alternative to the existing antioxidant supplement, antimicrobial compounds, and larvicidal systems. Additionally, further studies on the functional food aspect of the compounds will ensure the possible potential of these selected compounds as a nutraceutical against various diseases.

3. Materials and Methods

3.1. Chemicals and Reagents

The chemicals, reagents, and analytical-grade solvents were obtained from Sigma-Aldrich and local chemical companies. Bulk solvents used for purification or extraction and other general purposes were purified and dried before use by following standard procedures. Unless otherwise specified, chemicals or reagents were used as received from the suppliers without further purification. Chromatography was performed using Silica gel (60–120 and 100–200 mesh size). The progress and completion of the reaction were monitored by thin-layer chromatography (TLC). For this purpose, aluminum sheets pre-coated with silica gel (Merck, Kieselgel60, F254) were used.

3.2. Instruments Used for the Study

IR spectra were recorded on a Nicolet iS5 Thermo Fischer Scientific FT-IR spectrometer (Waltham, MA, USA). The spectral positions are given in the wavenumber (cm−1) unit. 1H and 13C NMR spectra of the compounds in CDCl3 were recorded using Bruker AMX-400 (400 MHz) spectrometer (Billerica, MA, USA). For 1H NMR spectra, the chemical shifts (δ) are reported in parts per million (ppm) relative to tetramethylsilane (TMS) as an internal standard. Coupling constants (J) are given in Hz. The spectrophotometric measurements were taken using UV 1280 Shimadzu UV/Visible spectrophotometer (Kyoto, Japan).

3.3. Synthesis and Characterization of Bis-Chalcones

The target bis-chalcone compounds with cyclohexanone and cyclopentanone cores were synthesized as outlined in Figure 2. The required chemicals such as ortho-chloro benzaldehyde, para-chloro benzaldehyde, para-methoxy benzaldehyde, cyclohexanone and cyclopentanone were obtained from Aldrich and used without further purification. Solvents and other reagents were obtained from local sources. The base-catalyzed Claisen–Schmidt condensation reaction of substituted benzaldehydes with cyclohexanone and cyclopentanone yielded the target compounds. In a typical reaction, the double mixed-aldol condensation reaction between a ketone and substituted benzaldehyde compound was carried out [16]. The ketone has α-hydrogens (on both sides) and thus can be deprotonated to give a nucleophilic enolate anion. The alkoxide produced is protonated by the solvent, giving a β-hydroxy ketone, which undergoes base-catalyzed dehydration. The elimination process is particularly fast in this case because the alkene is stabilized by conjugation not only to the carbonyl but also to the benzene. In this synthesis, two equivalents of the substituted benzaldehyde compound were used such that the aldol condensation could occur on both sides of the ketone. The aldehyde carbonyl is more reactive than that of the ketone and therefore reacts rapidly with the anion of the ketone to give a β-hydroxy ketone, which easily undergoes base-catalyzed dehydration (Figure 2). The molecular structures of all the target compounds were confirmed by standard spectroscopic methods of analysis. Detailed synthetic procedures for the compounds along with their characterization data are given as supplementary information.

3.4. Radical Generation Inhibition and Reducing Potential of the Synthetic Bis-Chalcones

The antiradical activity of the synthetic bis-chalcones was estimated against various radical generators including DPPH, ABTS, and nitric oxide according to the standard protocols mentioned by Lalhminghlui and Jagetia [59]. The reducing potential was assessed as the ferric reduction ability of the compounds as described by Youn et al. [60].

3.5. Antibacterial Activity of the Synthetic Bis-Chalcones by Disc Diffusion Method

The antibacterial activity was estimated against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Salmonella enteritidis strains. Briefly, the bacteria were grown in LB broth, and for the disc diffusion assay they were plated in an MHA agar plate (5 mm thickness). The plate was immersed with an 8 mm filter-paper disc corresponding to 20 μg/mL. The plates were incubated for 24 h in a bacteriological incubator and the inhibition zone was determined [61].

3.6. Analysis of the Larvicidal Activity of Synthetic Bis-Chalcones

The larvae of Aedes albopictus (third instar) were collected from the maintained culture; different concentrations of the synthetic bis-chalcones were added to glass jars (500 mL) and fifty larvae were put in each. The larvae were observed for 24 h for mortality. The percentage of death in each treatment was determined and the LC50 value was determined by probit analysis.

3.7. Cytotoxicity Analysis of Synthetic Bis-Chalcones

The MCF-7 and MDA-MB-231 cells were procured from the National Centre for Cell Science (Pune, Maharashtra). The cells were maintained according to the methods suggested by the supplier. The cytotoxicity was estimated using the MTT assay as described by the studies of Khanapure et al. [62]. The IC50 value was estimated using probit analysis using GraphPad Prism.

3.8. Statistical Analysis

The experimental results were initially sorted using spreadsheet software and statistical analysis was performed using GraphPad Prism version 7.0 (La Jolla, CA, USA). All the data were represented as mean ± SD for every experiment.

4. Conclusions

In this study, we synthesized six bis-chalcone compounds based on cyclohexanone and cyclopentanone cores. Their molecular structures were characterized by spectroscopic methods. The bis-chalones were different in their aromatic cores, functional group substitution, and position of substitutions. The compounds with a cyclohexanone core and –Cl substitution exhibited better antioxidant properties. In addition, compounds 1, 2, and 4 exhibited strong antibacterial activities against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Salmonella enteritidis. Apart from their antioxidant and antibacterial properties, the compounds also exhibited larvicidal properties. The effective control of mosquito populations by killing the larvae of the Aedes mosquito indicates their potential application in preventing infectious diseases and their vectors. The cytotoxic effect of these compounds is also indicative of their antineoplastic potentials. Our preliminary studies highlight the potential of bis-chalcones as pharmacologically active compounds and therefore further research with structural modifications with polar and non-polar substitutions is currently underway.

Supplementary Materials

The following supporting information can be downloaded at: https://0-www-mdpi-com.brum.beds.ac.uk/article/10.3390/molecules27238209/s1, Supplementary Figure S1: FT-IR spectrum of compound 1; Supplementary Figure S2: 1H NMR Spectrum of compound 1 in CDCl3; Supplementary Figure S3: FT-IR spectrum of compound 2; Supplementary Figure S4: 1H NMR Spectrum of compound 2 in CDCl3; Supplementary Figure S5: FT-IR spectrum of compound 3; Supplementary Figure S6: 1H NMR Spectrum of compound 3 in CDCl3; Supplementary Figure S7: FT-IR spectrum of compound 4; Supplementary Figure S8: 1H NMR Spectrum of compound 4 in CDCl3; Supplementary Figure S9: FT-IR spectrum of compound 5; Supplementary Figure S10: 1H NMR Spectrum of compound 5 in CDCl3; Supplementary Figure S11: 13C NMR Spectrum of compound 5 in CDCl3; Supplementary Figure S12: FT-IR spectrum of compound 6; Supplementary Figure S13: 1H NMR Spectrum of compound 6 in CDCl3.

Author Contributions

A.M.K., analysis, manuscript preparation, experimentation; D.N. analysis, manuscript preparation, experimentation R.R. analysis, manuscript preparation, experimentation, A.N.: Study design, methodology, experimentation, analysis, funding acquisition, manuscript editing. M.M., Study design, methodology, experimentation, analysis, funding acquisition, manuscript editing J.J., experimentation, supervision, manuscript editing O.J.O. Study design, methodology, experimentation, analysis, funding acquisition, manuscript editing and A.A.: Study design, methodology, experimentation, analysis, funding acquisition, manuscript editing. D.B.: Study design, analysis, manuscript editing. All authors have read and agreed to the published version of the manuscript.

Funding

The authors are grateful for the seed grant from Mohammed VI Polytechnic University, Morocco and funding support from Researchers Supporting Project Number (RSP2022R465), King Saud University, Riyadh, Saudi Arabia.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data may be shared upon valid request.

Acknowledgments

The authors are grateful for the seed grant from Mohammed VI Polytechnic University, Morocco. The authors also acknowledge the funding support from Researchers Supporting Project Number (RSP2022R465), King Saud University, Riyadh, Saudi Arabia. DBT-STAR (Project number: BT/HRD/11/09/2020) scheme supported Infrastructural development in St. Joseph’s College (Autonomous), Devagiri, Calicut.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are available from the authors.

References

  1. Nieto, G. How Are Medicinal Plants Useful When Added to Foods? Medicines 2020, 7, 58. [Google Scholar] [CrossRef]
  2. Vatansever, R.; Ozyigit, I.; Filiz, E. Essential and Beneficial Trace Elements in Plants, and Their Transport in Roots: A Review. Appl. Biochem. Biotechnol. 2017, 181, 464–482. [Google Scholar] [CrossRef]
  3. Choudhari, A.S.; Mandave, P.C.; Deshpande, M.; Ranjekar, P.; Prakash, O. Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice. Front. Pharmacol. 2020, 10, 1614. [Google Scholar] [CrossRef] [Green Version]
  4. Ashokkumar, K.; Murugan, M.; Dhanya, M.K.; Pandian, A.; Warkentin, T.D. Phytochemistry and therapeutic potential of black pepper [Piper nigrum (L.)] essential oil and piperine: A review. Clin. Phytosc. 2021, 7, 52. [Google Scholar] [CrossRef]
  5. Seca, A.M.L.; Pinto, D.C.G.A. Biological Potential and Medical Use of Secondary Metabolites. Medicines 2019, 6, 66. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Zhang, S.; Zhang, L.; Zou, H.; Qiu, L.; Zheng, Y.; Yang, D.; Wang, Y. Effects of Light on Secondary Metabolite Biosynthesis in Medicinal Plants. Front. Plant Sci. 2021, 11, 497. [Google Scholar] [CrossRef]
  7. Cory, H.; Passarelli, S.; Szeto, J.; Tamez, M.; Mattei, J. The Role of Polyphenols in Human Health and Food Systems: A Mini-Review. Front. Nutr. 2018, 5, 87. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Orlikova, B.; Tasdemir, D.; Golais, F.; Dicato, M.; Diederich, M. Dietary chalcones with chemopreventive and chemotherapeutic potential. Genes. Nutr. 2011, 6, 125–147. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Wu, X.; Zhang, S.; Liu, X.; Shang, J.; Zhang, A.; Zhu, Z.; Zha, D. Chalcone synthase (CHS) family members analysis from eggplant (Solanum melongena L.) in the flavonoid biosynthetic pathway and expression patterns in response to heat stress. PLoS ONE 2020, 15, e0226537. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Oldoni, T.L.C.; Cabral, I.S.R.; d’Arce, M.A.B.R.; Rosalen, P.L.; Ikegaki, M.; Nascimento, A.M.; Alencar, S.M. Isolation and analysis of bioactive isoflavonoids and chalcone from a new type of Brazilian propolis. Sep. Purif. Technol. 2011, 77, 208–213. [Google Scholar] [CrossRef]
  11. Escobar-Ramos, A.; Lobato-Garcia, C.E.; Zamilpa, A.; Gomez-Rivera, A.; Tortoriello, J.; Gonzalez-Cortazar, M. Homoisoflavonoids and Chalcones Isolated from Haematoxylum campechianum L. with Spasmolytic Activity. Molecules 2017, 22, 1405. [Google Scholar] [CrossRef]
  12. Park, J.Y.; Ko, J.A.; Kim, D.W.; Kim, Y.M.; Kwon, H.J.; Jeong, H.J.; Kim, C.Y.; Park, K.H.; Lee, W.S.; Ryu, Y.B. Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J. Enzym. Inhib. Med. Chem. 2016, 31, 23–30. [Google Scholar] [CrossRef] [Green Version]
  13. Xue, Y.; Liu, Y.; Luo, Q.; Wang, H.; Chen, R.; Liu, Y.; Li, Y. Antiradical Activity and Mechanism of Coumarin–Chalcone Hybrids: Theoretical Insights. J. Phys. Chem. A 2018, 122, 8520–8529. [Google Scholar] [CrossRef]
  14. Shin, J.E.; Choi, E.J.; Jin, Q.; Jin, H.G.; Woo, E.R. Chalcones isolated from Angelica keiskei and their inhibition of IL-6 production in TNF-alpha-stimulated MG-63 cell. Arch. Pharmacal Res. 2011, 34, 437–442. [Google Scholar] [CrossRef]
  15. Enoki, T.; Ohnogi, H.; Nagamine, K.; Kudo, Y.; Sugiyama, K.; Tanabe, M.; Kobayashi, E.; Sagawa, H.; Kato, I. Antidiabetic activities of chalcones isolated from a Japanese Herb, Angelica keiskei. J. Agric. Food Chem. 2007, 55, 6013–6017. [Google Scholar] [CrossRef]
  16. Jantan, I.; Mohd Yasin, Y.H.; Jamil, S.; Sirat, H.; Basar, N. Effect of prenylated flavonoids and chalcones isolated from Artocarpus species on platelet aggregation in human whole blood. J. Nat. Med. 2010, 64, 365–369. [Google Scholar] [CrossRef]
  17. Ngameni, B.; Touaibia, M.; Patnam, R.; Belkaid, A.; Sonna, P.; Ngadjui, B.T.; Annabi, B.; Roy, R. Inhibition of MMP-2 secretion from brain tumor cells suggests chemopreventive properties of a furanocoumarin glycoside and of chalcones isolated from the twigs of Dorstenia turbinata. Phytochemistry 2006, 67, 2573–2579. [Google Scholar] [CrossRef]
  18. Salehi, B.; Quispe, C.; Chamkhi, I.; El Omari, N.; Balahbib, A.; Sharifi-Rad, J.; Bouyahya, A.; Akram, M.; Iqbal, M.; Docea, A.O.; et al. Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence. Front. Pharmacol. 2021, 11, 592654. [Google Scholar] [CrossRef]
  19. Zhuang, C.; Zhang, W.; Sheng, C.; Zhang, W.; Xing, C.; Miao, Z. Chalcone: A Privileged Structure in Medicinal Chemistry. Chem Rev. 2017, 117, 7762–7810. [Google Scholar] [CrossRef]
  20. Okolo, E.N.; Ugwu, D.I.; Ezema, B.E.; Ndefo, J.C.; Eze, F.U.; Ezema, C.G.; Ezugwu, J.A.; Ujam, O.T. New chalcone derivatives as potential antimicrobial and antioxidant agent. Sci. Rep. 2021, 11, 21781. [Google Scholar] [CrossRef]
  21. Gupta, D.; Jain, D.K. Chalcone derivatives as potential antifungal agents: Synthesis, and antifungal activity. J. Adv. Pharm. Technol. Res. 2015, 6, 114–117. [Google Scholar] [CrossRef] [PubMed]
  22. Thapa, P.; Upadhyay, S.P.; Suo, W.Z.; Singh, V.; Gurung, P.; Lee, E.S.; Sharma, R.; Sharma, M. Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease. Bioorg. Chem. 2021, 108, 29. [Google Scholar] [CrossRef]
  23. Kucharíková, A.; Kusari, S.; Sezgin, S.; Spiteller, M.; Čellárová, E. Occurrence and Distribution of Phytochemicals in the Leaves of 17 In vitro Cultured Hypericum spp. Adapted to Outdoor Conditions. Front. Plant Sci. 2016, 7, 1616. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Forni, C.; Facchiano, F.; Bartoli, M.; Pieretti, S.; Facchiano, A.; D’Arcangelo, D.; Norelli, S.; Valle, G.; Nisini, R.; Beninati, S.; et al. Beneficial Role of Phytochemicals on Oxidative Stress and Age-Related Diseases. Biomed. Res. Int. 2019, 2019, 8748253. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Liargkova, T.; Hadjipavlou-Litina, D.J.; Koukoulitsa, C.; Voulgari, E.; Avgoustakis, C. Simple chalcones and bis-chalcones ethers as possible pleiotropic agents. J. Enzym. Inhib. Med. Chem. 2016, 31, 302–313. [Google Scholar] [CrossRef]
  26. Tajudeen Bale, A.; Mohammed Khan, K.; Salar, U.; Chigurupati, S.; Fasina, T.; Ali, F.; Wadood, A.; Taha, M.; Sekhar Nanda, S.; Ghufran, M.; et al. Chalcones and bis-chalcones: As potential α-amylase inhibitors; synthesis, in vitro screening, and molecular modelling studies. Bioorg. Chem. 2018, 79, 179–189. [Google Scholar] [CrossRef] [PubMed]
  27. Pisoschi, A.M.; Pop, A. The role of antioxidants in the chemistry of oxidative stress: A review. Eur. J. Med. Chem. 2015, 97, 55–74. [Google Scholar] [CrossRef] [PubMed]
  28. Sharifi-Rad, M.; Anil Kumar, N.V.; Zucca, P.; Varoni, E.M.; Dini, L.; Panzarini, E.; Rajkovic, J.; Tsouh Fokou, P.V.; Azzini, E.; Peluso, I.; et al. Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. Front. Physiol. 2020, 11, 694. [Google Scholar] [CrossRef]
  29. Moylan, J.S.; Reid, M.B. Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve 2007, 35, 411–429. [Google Scholar] [CrossRef]
  30. Liguori, I.; Russo, G.; Curcio, F.; Bulli, G.; Aran, L.; Della-Morte, D.; Gargiulo, G.; Testa, G.; Cacciatore, F.; Bonaduce, D.; et al. Oxidative stress, aging, and diseases. Clin. Interv. Aging 2018, 13, 757–772. [Google Scholar] [CrossRef]
  31. Xu, M.; Wu, P.; Shen, F.; Ji, J.; Rakesh, K.P. Chalcone derivatives and their antibacterial activities: Current development. Bioorg. Chem. 2019, 91, 103133. [Google Scholar] [CrossRef] [PubMed]
  32. Božić, D.D.; Milenković, M.; Ivković, B.; Ćirković, I. Antibacterial activity of three newly-synthesized chalcones & synergism with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus. Indian J. Med. Res. 2014, 140, 130–137. [Google Scholar] [PubMed]
  33. Koudokpon, H.; Armstrong, N.; Dougnon, T.V.; Fah, L.; Hounsa, E.; Bankolé, H.S.; Loko, F.; Chabrière, E.; Rolain, J.M. Antibacterial Activity of Chalcone and Dihydrochalcone Compounds from Uvaria chamae Roots against Multidrug-Resistant Bacteria. BioMed Res. Int. 2018, 2018, 1453173. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Satokata, A.A.C.; Souza, J.H.; Silva, L.L.O.; Santiago, M.B.; Ramos, S.B.; Assis, L.R.; Theodoro, R.S.; Oliveira, L.R.; Regasini, L.O.; Martins, C.H.G. Chalcones with potential antibacterial and antibiofilm activities against periodontopathogenic bacteria. Anaerobe 2022, 76, 102588. [Google Scholar] [CrossRef]
  35. Kunthalert, D.; Baothong, S.; Khetkam, P.; Chokchaisiri, S.; Suksamrarn, A. A chalcone with potent inhibiting activity against biofilm formation by nontypeable Haemophilus influenzae. Microbiol. Immunol. 2014, 58, 581–589. [Google Scholar] [CrossRef]
  36. Bozic, D.D.; Milenkovic, M.; Ivkovic, B.; Cirkovic, I. Newly-synthesized chalcones-inhibition of adherence and biofilm formation of methicillin-resistant Staphylococcus aureus. Braz. J. Microbiol. 2014, 45, 263–270. [Google Scholar] [CrossRef]
  37. Uchil, A.; Murali, T.S.; Nayak, R. Escaping ESKAPE: A chalcone perspective. Results Chem. 2021, 3, 100229. [Google Scholar] [CrossRef]
  38. Hellewell, L.; Bhakta, S. Chalcones, stilbenes and ketones have anti-infective properties via inhibition of bacterial drug-efflux and consequential synergism with antimicrobial agents. Access Microbiol. 2020, 2, acmi000105. [Google Scholar] [CrossRef]
  39. Goncalves Mendes Neto, A.; Lo, K.B.; Wattoo, A.; Salacup, G.; Pelayo, J.; DeJoy, R., III; Bhargav, R.; Gul, F.; Peterson, E.; Albano, J.; et al. Bacterial infections and patterns of antibiotic use in patients with COVID-19. J. Med. Virol. 2021, 93, 1489–1495. [Google Scholar] [CrossRef]
  40. Murray, C.J.L.; Ikuta, K.S.; Sharara, F.; Swetschinski, L.; Robles Aguilar, G.; Gray, A.; Han, C.; Bisignano, C.; Rao, P.; Wool, E.; et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022, 399, 629–655. [Google Scholar] [CrossRef]
  41. Qin, S.; Xiao, W.; Zhou, C.; Pu, Q.; Deng, X.; Lan, L.; Liang, H.; Song, X.; Wu, M. Pseudomonas aeruginosa: Pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct. Target. Ther. 2022, 7, 022–01056. [Google Scholar] [CrossRef] [PubMed]
  42. Nakao, J.H.; Talkington, D.; Bopp, C.A.; Besser, J.; Sanchez, M.L.; Guarisco, J.; Davidson, S.L.; Warner, C.; McIntyre, M.G.; Group, J.P.; et al. Unusually high illness severity and short incubation periods in two foodborne outbreaks of Salmonella Heidelberg infections with potential coincident Staphylococcus aureus intoxication. Epidemiol. Infect. 2018, 146, 19–27. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Akbar, A.; Anal, A.K. Prevalence and antibiogram study of Salmonella and Staphylococcus aureus in poultry meat. Asian Pac. J. Trop. Biomed. 2013, 3, 163–168. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Targanski, S.K.; Sousa, J.R.; de Pádua, G.M.; de Sousa, J.M.; Vieira, L.C.; Soares, M.A. Larvicidal activity of substituted chalcones against Aedes aegypti (Diptera: Culicidae) and non-target organisms. Pest Manag. Sci. 2021, 77, 325–334. [Google Scholar] [CrossRef]
  45. Begum, N.A.; Roy, N.; Laskar, R.A.; Roy, K. Mosquito larvicidal studies of some chalcone analogues and their derived products: Structure–activity relationship analysis. Med. Chem. Res. 2011, 20, 184–191. [Google Scholar] [CrossRef]
  46. Pasquale, G.; Romanelli, G.P.; Autino, J.C.; García, J.; Ortiz, E.V.; Duchowicz, P.R. Quantitative Structure–Activity Relationships of Mosquito Larvicidal Chalcone Derivatives. J. Agric. Food Chem. 2012, 60, 692–697. [Google Scholar] [CrossRef]
  47. Weetman, D.; Kamgang, B.; Badolo, A.; Moyes, C.L.; Shearer, F.M.; Coulibaly, M.; Pinto, J.; Lambrechts, L.; McCall, P.J. Aedes Mosquitoes and Aedes-Borne Arboviruses in Africa: Current and Future Threats. Int. J. Environ. Res. Public Health 2018, 15, 220. [Google Scholar] [CrossRef] [Green Version]
  48. Aragão, C.F.; Pinheiro, V.C.S.; Nunes Neto, J.P.; Silva, E.; Pereira, G.J.G.; Nascimento, B.; Castro, K.D.S.; Maia, A.M.; Catete, C.P.; Martins, L.C.; et al. Natural Infection of Aedes aegypti by Chikungunya and Dengue type 2 Virus in a Transition Area of North-Northeast Brazil. Viruses 2019, 11, 1126. [Google Scholar] [CrossRef] [Green Version]
  49. Gloria-Soria, A.; Armstrong, P.M.; Powell, J.R.; Turner, P.E. Infection rate of Aedes aegypti mosquitoes with dengue virus depends on the interaction between temperature and mosquito genotype. Proc. Biol. Sci. 2017, 284, 1864. [Google Scholar]
  50. Mourya, D.T.; Gokhale, M.D.; Majumdar, T.D.; Yadav, P.D.; Kumar, V.; Mavale, M.S. Experimental Zika virus infection in Aedes aegypti: Susceptibility, transmission & co-infection with dengue & chikungunya viruses. Indian J. Med. Res. 2018, 147, 88–96. [Google Scholar]
  51. Hegde, S.M.; Kumar, M.N.; Kavya, K.; Kumar, K.M.; Nagesh, R.; Patil, R.H.; Babu, R.L.; Ramesh, G.T.; Sharma, S.C. Interplay of nuclear receptors (ER, PR, and GR) and their steroid hormones in MCF-7 cells. Mol. Cell. Biochem. 2016, 422, 109–120. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Fog, C.K.; Christensen, I.J.; Lykkesfeldt, A.E. Characterization of a human breast cancer cell line, MCF-7/RU58R-1, resistant to the pure antiestrogen RU 58,668. Breast Cancer Res. Treat. 2005, 91, 133–144. [Google Scholar] [CrossRef] [PubMed]
  53. Leung, E.; Kannan, N.; Krissansen, G.W.; Findlay, M.P.; Baguley, B.C. MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity. Cancer Biol. Ther. 2010, 9, 717–724. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Mielczarek, L.; Krug, P.; Mazur, M.; Milczarek, M.; Chilmonczyk, Z.; Wiktorska, K. In the triple-negative breast cancer MDA-MB-231 cell line, sulforaphane enhances the intracellular accumulation and anticancer action of doxorubicin encapsulated in liposomes. Int. J. Pharm. 2019, 558, 311–318. [Google Scholar] [CrossRef]
  55. Al-Bader, M.; Ford, C.; Al-Ayadhy, B.; Francis, I. Analysis of estrogen receptor isoforms and variants in breast cancer cell lines. Exp. Ther. Med. 2011, 2, 537–544. [Google Scholar] [CrossRef] [Green Version]
  56. Kalinina, T.S.; Kononchuk, V.V.; Gulyaeva, L.F. Expression of estrogen-, progesterone-, and androgen-responsive genes in MCF-7 and MDA-MB-231 cells treated with o,p’-DDT, p,p’-DDT, or endosulfan. J. Biochem. Mol. Toxicol. 2021, 35, 1–8. [Google Scholar] [CrossRef]
  57. Constantinescu, T.; Lungu, C.N. Anticancer Activity of Natural and Synthetic Chalcones. Int. J. Mol. Sci. 2021, 22, 11306. [Google Scholar] [CrossRef]
  58. Ouyang, Y.; Li, J.; Chen, X.; Fu, X.; Sun, S.; Wu, Q. Chalcone Derivatives: Role in Anticancer Therapy. Biomolecules 2021, 11, 894. [Google Scholar] [CrossRef]
  59. Lalhminghlui, K.; Jagetia, G.C. Evaluation of the free-radical scavenging and antioxidant activities of Chilauni, Schima wallichii Korth in vitro. Future Sci. OA 2018, 4, FSO272. [Google Scholar] [CrossRef] [Green Version]
  60. Youn, J.S.; Kim, Y.J.; Na, H.J.; Jung, H.R.; Song, C.K.; Kang, S.Y.; Kim, J.Y. Antioxidant activity and contents of leaf extracts obtained from Dendropanax morbifera LEV are dependent on the collecting season and extraction conditions. Food Sci. Biotechnol. 2018, 28, 201–207. [Google Scholar] [CrossRef]
  61. Walia, S.; Mukhia, S.; Bhatt, V.; Kumar, R.; Kumar, R. Variability in chemical composition and antimicrobial activity of Tagetes minuta L. essential oil collected from different locations of Himalaya. Ind. Crops Prod. 2020, 150, 112449. [Google Scholar] [CrossRef]
  62. Khanapure, S.; Jagadale, M.; Bansode, P.; Choudhari, P.; Rashinkar, G. Anticancer activity of ruthenocenyl chalcones and their molecular docking studies. J. Mol. Struct. 2018, 1173, 142–147. [Google Scholar] [CrossRef]
Molecules 27 08209 g001 550
Figure 1. Molecular structures of synthetic chalcones 1 to 6.
Figure 1. Molecular structures of synthetic chalcones 1 to 6.
Molecules 27 08209 g001
Molecules 27 08209 g002 550
Figure 2. Synthetic route for the target compounds.
Figure 2. Synthetic route for the target compounds.
Molecules 27 08209 g002
Table
Table 1. Antiradical properties of different synthetic bis-chalcones.
Table 1. Antiradical properties of different synthetic bis-chalcones.
DPPH
(IC50 µg/mL)		ABTS
(IC50 µg/mL)		Nitric Oxide
(IC50 µg/mL)		FRAP
(EC50 µg/mL)
(2E,6E)-2,6-bis(4-methoxybenzylidene) cyclohexanone (compound 1)18.41 ± 1.4518.63 ± 1.4128.87 ± 1.491.35 ± 0.10
(2E,6E)-2,6-bis(4-chlorobenzylidene) cyclohexanone (compound 2)19.92 ± 1.5221.57 ± 1.5526.04 ± 1.615.24 ± 0.21
(2E,6E)-2,6-bis(2-chlorobenzylidene) cyclohexanone (compound 3)27.75 ± 2.5026.47 ± 1.4234.30 ± 2.5512.40 ± 0.20
(2E,5E)-2,5-bis(4-(tetrahydro-2H-pyran-2-yloxy) benzylidene) cyclopentanone (compound 4)25.42 ± 1.3922.18 ± 1.2929.15 ± 1.724.34 ± 0.11
2,5-bis(4-hydroxybenzylidene) cyclopentanone (compound 5)36.49 ± 1.5542.10 ± 2.2745.67 ± 3.0415.61 ± 0.30
4-(tetrahydro-2H-pyran-2-yloxy) benzaldehyde (compound 6)35.47 ± 1.6446.17 ± 3.2349.09 ± 3.1116.20 ± 0.24
Table
Table 2. Efficacy of synthetic bis-chalcones against Gram-positive and Gram-negative bacterial strains as indicated by the zone of inhibition by the disc diffusion method.
Table 2. Efficacy of synthetic bis-chalcones against Gram-positive and Gram-negative bacterial strains as indicated by the zone of inhibition by the disc diffusion method.
BacteriaCompounds with Zone of Inhibition (mm)
123456
Escherichia coli18.4 ± 0.122.5 ± 0.2 *16.7 ± 0.320.6 ± 0.3 *17.7 ± 0.316.4 ± 0.1
Pseudomonas aeruginosa19.8 ± 0.2 *19.1 ± 0.2 *14.7 ± 0.220.1 ± 0.316.9 ± 0.215.0 ± 0.3
Staphylococcus aureus18.5 ± 0.120.1 ± 0.3 *13.7 ± 0.119.5 ± 0.2 *15.1 ± 0.214.6 ± 0.3
Salmonella enteritidis18.2 ± 0.119.0 ± 0.3 *15.4 ± 0.218.6 ± 0.1 *16.0 ± 0.217.4 ± 0.1
Table
Table 3. Larvicidal properties of different synthetic bis-chalcones against Aedes albopictus.
Table 3. Larvicidal properties of different synthetic bis-chalcones against Aedes albopictus.
CompoundLC50 (µg/mL)
(2E,6E)-2,6-bis(4-methoxybenzylidene) cyclohexanone (compound 1)45.27 ± 2.34
(2E,6E)-2,6-bis(4-chlorobenzylidene) cyclohexanone (compound 2)59.81 ± 2.09
(2E,6E)-2,6-bis(2-chlorobenzylidene) cyclohexanone (compound 3)99.04 ± 2.18
(2E,5E)-2,5-bis(4-(tetrahydro-2H-pyran-2-yloxy) benzylidene) cyclopentanone (compound 4)56.46 ± 3.07
2,5-bis(4-hydroxybenzylidene) cyclopentanone (compound 5)89.22 ± 3.12
4-(tetrahydro-2H-pyran-2-yloxy) benzaldehyde (compound 6)79.18 ± 2.69
Table
Table 4. Cytotoxicity evaluation of the synthetic bis-chalcones against human cancer cells and results are expressed as IC50 values.
Table 4. Cytotoxicity evaluation of the synthetic bis-chalcones against human cancer cells and results are expressed as IC50 values.
CompoundLC50 (µg/mL)
MCF-7MDA-MB-231
(2E,6E)-2,6-bis(4-methoxybenzylidene) cyclohexanone (compound 1)86.13 ± 3.45128.66 ± 3.62
(2E,6E)-2,6-bis(4-chlorobenzylidene) cyclohexanone (compound 2)79.51 ± 2.8597.64 ± 3.15
(2E,6E)-2,6-bis(2-chlorobenzylidene) cyclohexanone (compound 3)132.49 ± 3.71160.54 ± 5.22
(2E,5E)-2,5-bis(4-(tetrahydro-2H-pyran-2-yloxy) benzylidene) cyclopentanone (compound 4)71.09 ± 2.3489.62 ± 2.18
2,5-bis(4-hydroxybenzylidene) cyclopentanone (compound 5)103.56 ± 2.48141.05 ± 4.84
4-(tetrahydro-2H-pyran-2-yloxy) benzaldehyde (compound 6)109.82 ± 4.10155.32 ± 5.03
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kuttithodi, A.M.; Nikhitha, D.; Jacob, J.; Narayanankutty, A.; Mathews, M.; Olatunji, O.J.; Rajagopal, R.; Alfarhan, A.; Barcelo, D. Antioxidant, Antimicrobial, Cytotoxicity, and Larvicidal Activities of Selected Synthetic Bis-Chalcones. Molecules 2022, 27, 8209. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules27238209

AMA Style

Kuttithodi AM, Nikhitha D, Jacob J, Narayanankutty A, Mathews M, Olatunji OJ, Rajagopal R, Alfarhan A, Barcelo D. Antioxidant, Antimicrobial, Cytotoxicity, and Larvicidal Activities of Selected Synthetic Bis-Chalcones. Molecules. 2022; 27(23):8209. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules27238209

Chicago/Turabian Style

Kuttithodi, Aswathi Moothakoottil, Divakaran Nikhitha, Jisha Jacob, Arunaksharan Narayanankutty, Manoj Mathews, Opeyemi Joshua Olatunji, Rajakrishnan Rajagopal, Ahmed Alfarhan, and Damia Barcelo. 2022. "Antioxidant, Antimicrobial, Cytotoxicity, and Larvicidal Activities of Selected Synthetic Bis-Chalcones" Molecules 27, no. 23: 8209. https://0-doi-org.brum.beds.ac.uk/10.3390/molecules27238209

Article Metrics

Back to TopTop